Mitral valve repair with artificial chordae replacement in children: a single-center experience

Yaojun Dun1, Jiayi Xing2, Dong Zhao1

  • 1Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167# Beilishi Road, Xicheng District, Beijing, 100037, China.

Insights

Mitral valve repair using artificial chordae in children shows acceptable outcomes, particularly for simple lesions and older children. Long-term success is promising, with specific patient groups demonstrating better results.

Area of Science:

  • Pediatric cardiology
  • Cardiac surgery
  • Biomaterials in medicine

Background:

  • Mitral valve (MV) disease in children can lead to significant morbidity.
  • Surgical repair, including artificial chordae replacement, is an option for pediatric MV disease.
  • Understanding outcomes of this specific repair technique in children is crucial for clinical decision-making.

Purpose of the Study:

  • To evaluate the early and intermediate outcomes of mitral valve repair with artificial chordae replacement in pediatric patients.
  • To identify factors influencing the success of this surgical technique in children.

Main Methods:

  • Retrospective review of pediatric patients (<18 years) undergoing MV repair with artificial chordae replacement from 2011-2019.
  • Kaplan-Meier analysis and log-rank testing to estimate freedom from MV reoperation and dysfunction.
  • Stratification of patients based on lesion complexity (simple vs. complex) and age (<12 vs. >12 years).

Main Results:

  • Thirty pediatric patients were analyzed, with 15 having simple and 15 complex lesions.
  • At 36 months follow-up, freedom from MV reoperation was 91.3% at 5 and 8 years.
  • Freedom from MV dysfunction at 5 years was 61.8%, with significantly better outcomes in simple lesions (100%) and older children (>12 years, 90.0%).

Conclusions:

  • Mitral valve repair with artificial chordae replacement offers acceptable early and intermediate outcomes in children.
  • Outcomes are significantly better for pediatric patients with simple mitral valve lesions.
  • Older children (over 12 years) also experience more favorable results with this repair technique.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
142
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
108
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
121
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
168
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
153
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
159